CLINICAL_TRIALS
trial_result
· 2025-10-10
Clinical Trial Update: Ketamine-enhanced Prolonged Exposure Therapy in PTSD [Phase 2]
Summary
A Phase 2 clinical trial investigating ketamine-augmented prolonged exposure therapy for post-traumatic stress disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 2 | Status: COMPLETED